HomePage | Biosensors International Ltd
Biosensors Launches Chroma at EuroPCR We have launched Chroma™, our innovative cobalt chromium bare-metal stent (BMS), at EuroPCR 2014.
Chroma received CE Mark approval in October 2013 and is now in the process of being launched in most major European markets and selected regions in the Middle East, Africa and Asia.
BioMatrix NEOFLEX™
BioMatrix NeoFlex™ is the latest addition to the BioMatrix family of drug-eluting stents (DES).™
It features an enhanced catheter delivery system with a lower entry profile than its predecessor, so improving pushability, trackability and crossability. BioMatrix NeoFlex retains the same unique combination of abluminal biodegradable polymer coating, Biolimus A9™ and flexible platform which have made the BioMatrix family of DES so popular.

Spotlight BioFreedom™
Spotlight BioFreedom™ DAPT
Duration: How Low Can You Go?
An update on BioFreedom clinical trials around the world, featuring interviews with the Principal Investigators from LEADERS Free; LEADERS Free Japan; The US IDE trial; and EGO BioFreedom.
Watch the video
1 month DAPT: BioFreedom™ –
a patient-centric approach to coronary stenting.
This TCT 2014 symposium discussed potential for improving patient experienceof stenting by lowering the duration of DAPT.
FY15 Q2 and 1st Half Financial Results Webcast Wednesday, 12 November 2014, 6pm Singapore time